Article
Metformin, empagliflozin and their combination modulate ex-vivo macrophage inflammatory gene expression
2022-06-20
Abstract excerpt
Type-2 Diabetes Mellitus is a complex, chronic illness characterized by persistent high blood glucose levels. Patients can be prescribed anti-diabetes drugs as single agents or in combination depending on the severity of their condition. Metformin and empagliflozin are two commonly prescribed anti-diabetes drugs which reduce hyperglycemia, however their direct effects on macrophage inflammatory responses alone or...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a070dd03-a08c-52ea-8832-43483dfd058d
- DOI
- 10.1101/2022.06.20.496771
